Is misonidazole neurotoxicity altered by the use of phenytoin and/or dexamethasone in RTOG 79-18 and RTOG 79-16?
- 1 September 1984
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 10 (9) , 1731-1734
- https://doi.org/10.1016/0360-3016(84)90538-8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus bcnu for treatment of malignant glioma after surgery; Preliminary results of an RTOG studyInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Misonidazole in patients receiving radical radiotherapy: Pharmac-okinetic effects of phenytoin tumor response and neurotoxicityInternational Journal of Radiation Oncology*Biology*Physics, 1982
- High dose misonidazole with dexamethasone rescue: A possible approach to circumvent neurotoxicityInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Clinical experience with nitroimidazoles as radiosensitizersInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Phenytoin shortens the half-life of the hypoxic cell radiosensitizer misonidazole in man: implications for possible reduced toxicityBritish Journal of Cancer, 1980
- Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of misonidazole in miceBritish Journal of Cancer, 1979
- Initial United States clinical and pharmacologic evaluation of misonidazole (Ro-07-0582), an hypoxic cell radiosensitizerInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Misonidazole—A drug for trial in radiotherapy and oncologyInternational Journal of Radiation Oncology*Biology*Physics, 1979